EUVIMEDEUVIMED entdecken
Crossref

Impact of VA-ECMO Bridging on Heart Transplant: Outcomes and Complications

R. Saleh, L. Conci, T. Schlöglhofer, R. Moayedifar, J. Riebandt, A. Aliabadi-Zuckermann, D. Zimpfer, A. Zuckermann, E. Osorio

The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 01 S 01) · S1-S70

DOI: 10.1055/s-0046-1817309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von R. Saleh und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

All articles of this category (opens in new window)

Background

The recent change in the UNOS allocation policy in 2018 has led to a marked increase in the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) as a bridge to transplantation (BTT) in patients with end-stage heart failure. Despite its growing application, evidence on outcomes and complications during VA-ECMO bridging remains limited. This retrospective single-center study aims to compare short- and long-term posttransplant outcomes between patients bridged with VA-ECMO and those transplanted without ECMO, and to identify key complications during ECMO support, particularly stroke and infection.

Methods

A total of 394 patients between January 1, 2012, and January 1, 2022, were included, of whom 21 (5.3%) were bridged with VA-ECMO. One-year survival was assessed using the Kaplan–Meier method, and risk factors were analyzed using univariate and multivariate Cox regression models. A second analysis examined all patients evaluated for HTX on VA-ECMO ( n = 42), comparing the transplanted ( n = 21) and nontransplanted cohort ( n = 21).

Results

One-year survival did not differ significantly between VA-ECMO and non-VA-ECMO groups ( p = 0.894). In the multivariate analysis, postoperative ECMO support emerged as the strongest independent predictor of 1-year mortality (HR= 4.18, 95% CI: 2.07–8.47, p < 0.001), followed by renal replacement therapy (HR=3.29, 95% CI: 1.58–6.84, p = 0.01) and elevated bilirubin at the time of transplantation (HR= 1.19; 95% CI: 1.03–1.38, p = 0.017). ECMO as BTT was not independently associated with reduced posttransplant survival (HR=0.5, 95% CI: 0.1–2.45, p = 0.393). Adverse events during ECMO occurred in 47.6% of patients, most frequently bleeding 23.81%, distal perfusion cannula dysfunction 28.56%, and heparin-induced thrombocytopenia 19.05%. Of 42 patients evaluated for HTX on VA-ECMO, only 21 underwent transplantation, while the remainder were weaned ( n = 4), died on support ( n = 3), or required durable MCS ( n = 14). Transplanted patients were younger, 41 (32–56) vs. 58 (46–63) years ( p = 0.002), with a different blood group distribution ( p = 0.044).

Conclusion

VA-ECMO as BTT can achieve comparable 1-year survival to transplantation without ECMO when applied in carefully selected patients. However, its use is associated with a high incidence of complications, underscoring the importance of vigilant monitoring, structured management protocols, and multidisciplinary decision-making in this high-risk population. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Saleh, R., Conci, L., Schlöglhofer, T., Moayedifar, R., Riebandt, J., Aliabadi-Zuckermann, A., Zimpfer, D., Zuckermann, A., & Osorio, E. (2026). Impact of VA-ECMO Bridging on Heart Transplant: Outcomes and Complications. The Thoracic and Cardiovascular Surgeon, 74(S 01 S 01), S1-S70. https://doi.org/10.1055/s-0046-1817309

Vancouver

Saleh R, Conci L, Schlöglhofer T, Moayedifar R, Riebandt J, Aliabadi-Zuckermann A, et al. Impact of VA-ECMO Bridging on Heart Transplant: Outcomes and Complications. The Thoracic and Cardiovascular Surgeon. 2026;74(S 01 S 01):S1-S70. doi:10.1055/s-0046-1817309

BibTeX
@article{Saleh2026,
  author = {Saleh, R. and Conci, L. and Schlöglhofer, T. and Moayedifar, R. and Riebandt, J. and Aliabadi-Zuckermann, A. and Zimpfer, D. and Zuckermann, A. and Osorio, E.},
  title = {Impact of VA-ECMO Bridging on Heart Transplant: Outcomes and Complications},
  journal = {The Thoracic and Cardiovascular Surgeon},
  year = {2026},
  volume = {74},
  number = {S 01 S 01},
  pages = {S1--S70},
  doi = {10.1055/s-0046-1817309}
}
Kostenlos starten →